Fabio Cominelli Selected Research

Ileitis

11/2021	Replacing Animal Protein with Soy-Pea Protein in an "American Diet" Controls Murine Crohn Disease-Like Ileitis Regardless of Firmicutes: Bacteroidetes Ratio.
1/2021	NOD2 drives early IL-33-dependent expansion of group 2 innate lymphoid cells during Crohn's disease-like ileitis.
11/2020	Human Gut Microbiome Transplantation in Ileitis Prone Mice: A Tool for the Functional Characterization of the Microbiota in Inflammatory Bowel Disease Patients.
12/2019	Neutralization of IL-1α ameliorates Crohn's disease-like ileitis by functional alterations of the gut microbiome.
1/2019	Crohn's Disease-Like Ileitis and the Inhibitory Effect of Sucralose on Streptococci.
1/2019	TWEAK/Fn14 Is Overexpressed in Crohn's Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune Pathways.
1/2019	Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
11/2018	Inhibition of autotaxin alleviates inflammation and increases the expression of sodium-dependent glucose cotransporter 1 and Na+/H+ exchanger 3 in SAMP1/Fc mice.
1/2018	The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn's Disease-Like Ileitis.
1/2018	Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabio Cominelli Research Topics

Disease

43	Inflammation (Inflammations) 01/2022 - 04/2003
41	Ileitis 11/2021 - 11/2002
30	Crohn Disease (Crohn's Disease) 11/2021 - 11/2002
19	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 12/2002
14	Colitis 01/2022 - 08/2004
5	Ulcerative Colitis 01/2022 - 09/2006
5	Dysbiosis 01/2022 - 01/2016
4	Disease Progression 01/2018 - 04/2003
3	Neoplasms (Cancer) 01/2021 - 11/2016
3	Carcinogenesis 01/2021 - 01/2017
2	Gastritis 01/2021 - 11/2011
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2017
2	Colitis-Associated Neoplasms 04/2020 - 01/2017
2	Necrosis 01/2016 - 07/2005
2	Liver Diseases (Liver Disease) 07/2015 - 03/2003
1	Infections 01/2022
1	Precancerous Conditions 01/2021
1	Metaplasia 01/2021
1	Clostridium Infections 12/2020
1	Communicable Diseases (Infectious Diseases) 12/2020
1	COVID-19 01/2020
1	Obesity 01/2020
1	Intestinal Diseases (Diseases, Intestinal) 01/2019
1	Body Weight (Weight, Body) 11/2018
1	Weight Gain 11/2018
1	Adenoma (Adenomas) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

23	CytokinesIBA 01/2022 - 11/2002
22	4-(4-sulfophenylazo)-2-mercuriphenol (SAMP)IBA 11/2021 - 02/2005
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2002
7	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022 - 11/2006
7	Dextrans (Dextran)FDA Link 01/2022 - 11/2006
6	Proteins (Proteins, Gene)FDA Link 11/2021 - 11/2003
4	Member 25 Tumor Necrosis Factor ReceptorsIBA 01/2018 - 05/2006
3	InterleukinsIBA 01/2022 - 01/2016
3	Tight Junction ProteinsIBA 01/2022 - 03/2006
3	Interleukin-33IBA 01/2021 - 04/2016
3	Interleukin-5 (Interleukin 5)IBA 01/2021 - 03/2005
3	LigandsIBA 01/2019 - 04/2006
3	Interleukin-13IBA 11/2018 - 03/2005
3	Interleukin-4 (Interleukin 4)IBA 11/2018 - 03/2005
3	IntegrinsIBA 01/2016 - 02/2005
3	L-SelectinIBA 04/2006 - 08/2004
3	Messenger RNA (mRNA)IBA 03/2006 - 11/2003
2	Sweetening Agents (Sweeteners)IBA 01/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 11/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2020 - 01/2020
2	SteroidsIBA 11/2020 - 09/2006
2	Interleukin-1 (Interleukin 1)IBA 12/2019 - 09/2012
2	Monoclonal AntibodiesIBA 12/2019 - 01/2016
2	trichlorosucrose (sucralose)IBA 01/2019 - 01/2018
2	Vitamin D FDA LinkGeneric 11/2017 - 11/2015
2	Biological ProductsIBA 11/2017 - 07/2017
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 01/2014
2	AntibodiesIBA 01/2017 - 07/2003
2	Interleukin-6 (Interleukin 6)IBA 11/2016 - 02/2008
2	Interleukin-23 (Interleukin 23)IBA 01/2016 - 07/2007
2	OccludinIBA 01/2012 - 03/2006
2	Claudin-2IBA 01/2012 - 03/2006
2	integrin beta7IBA 11/2010 - 02/2005
2	Chemokine ReceptorsIBA 02/2008 - 11/2006
2	Infliximab (Remicade)FDA Link 05/2007 - 09/2006
2	Cell Adhesion Molecule-1IBA 04/2006 - 02/2005
1	MucinsIBA 01/2022
1	Immunomodulating AgentsIBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	Drinking WaterIBA 01/2022
1	Pea ProteinsIBA 11/2021
1	CarbohydratesIBA 11/2021
1	spasmolytic polypeptideIBA 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021
1	Histidine (L-Histidine)FDA Link 11/2020
1	Leucine (L-Leucine)FDA Link 11/2020
1	Isoleucine (L-Isoleucine)FDA Link 11/2020
1	Valine (L-Valine)FDA Link 11/2020
1	Mucin-2IBA 04/2020
1	SolutionsIBA 01/2020
1	SuspensionsIBA 01/2020
1	Dietary Fats (Dietary Fat)IBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2019
1	LipocalinsIBA 01/2019
1	Thiram FDA Link 01/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2019
1	SodiumIBA 11/2018
1	Glucose (Dextrose)FDA LinkGeneric 11/2018
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 11/2018
1	6- (3- (piperazin- 1- yl)propanoyl)benzo(d)oxazol- 2(3H)- oneIBA 11/2018
1	16S Ribosomal RNAIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	maltodextrinIBA 01/2018
1	Tumor Necrosis Factor InhibitorsIBA 11/2017
1	Natalizumab (Tysabri)FDA Link 11/2017
1	ElementsIBA 07/2017
1	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2017

Therapy/Procedure

20	Therapeutics 01/2022 - 11/2002
4	Fecal Microbiota Transplantation 01/2022 - 01/2016
3	Transplantation 03/2021 - 04/2016
1	Complementary Therapies (Alternative Medicine) 12/2017
1	Injections 01/2017